Response | Filed: September 10, 2026
| Entered: September 10, 2026
Providence St. Joseph Health et al v. Actavis Holdco US, Inc. et al
Other Statutes: Anti-Trust | Pennsylvania Eastern
Response
Response /Defendants' Objection to Special Master Stengel's Report and Recommendation Resolving Defendants' Second Motion to Compel Hospitals re 445 REPORT AND RECOMMENDATIONS re (413 in 5:23-cv-03636-CMR) Second MOTION to Compel Discovery From Hospital Plaintiffs filed by BAUSCH HEALTH AMERICAS, INC., BAUSCH HEALTH US, LLC, (4558 in 2:16-md-02724-CMR) Second MOTION to Compel Disc by ACTAVIS ELIZABETH LLC, ACTAVIS HOLDCO U.S. INC., ACTAVIS PHARMA, INC., AMNEAL PHARMACEUTICALS LLC, ARA APRAHAMIAN, AUROBINDO PHARMA U.S.A., INC., BAUSCH HEALTH AMERICAS, INC., BAUSCH HEALTH US, LLC, BRECKENRIDGE PHARMACEUTICAL, INC., JAMES BROWN, David Berthold, Mitchell Blashinsky, Douglas Boothe, CITRON PHARMA LLC, Dr Reddys Laboratories, Inc., EMCURE PHARMACEUTICALS LTD., EPIC PHARMA LLC, FOUGERA PHARMACEUTICALS INC., Marc Falkin, G&W LABORATORIES, INC., GLENMARK GENERICS INC., USA, GLENMARK PHARMACEUTICALS INC, USA, KEVIN GREEN, GREENSTONE LLC, James Grauso, ROBIN HATOSY, HERITAGE PHARMACEUTICALS INC, HIKMA LABS, INC., HIKMA PHARMACEUTICALS USA INC., IMPAX LABORATORIES, LLC, JUBILANT CADISTA PHARMACEUTICALS INC., HECTOR ARMANDO KELLUM, LANNETT COMPANY, INC., LUPIN PHARMACEUTICALS INC., RAJIV MALIK, MAYNE PHARMA INC., SATISH MEHTA, MYLAN INC, Mylan Pharmaceuticals, Inc.,, Jill Nailor, James Nesta, Konstantin Ostaficiuk, NISHA PATEL, PERRIGO NEW YORK INC., Padagis US LLC, Michael Perfetto, Pfizer Inc, David Rekenthaler, Richard Rogerson, SANDOZ INC., SUN PHARMACEUTICAL INDUSTRIES INC., Strides Pharma Inc., Tracy Sullivan DiValerio, TARO PHARMACEUTICALS U.S.A., INC, TEVA PHARMACEUTICALS (USA) INC., TORRENT PHARMA INC., UPSHER-SMITH LABORATORIES, LLC, VIATRIS INC., JOHN WESOLOWSKI, WEST-WARD COLUMBUS, INC., WEST-WARD PHARMACEUTICALS INC., ZYDUS PHARMACEUTICALS (USA) INC.. (Attachments: # 1 Exhibit A, # 2 Text of Proposed Order) (ADELSTEIN, ROBIN)
Response | Filed: September 10, 2026
| Entered: September 10, 2026
IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION
Other Statutes: Anti-Trust | Pennsylvania Eastern
Response
Response /Defendants' Objection to Special Master Stengel's Report and Recommendation Resolving Defendants' Second Motion to Compel Hospitals re 4962 Report Of by ACTAVIS ELIZABETH, LLC, ACTAVIS HOLDCO U.S., INC., ACTAVIS PHARMA, INC., AMNEAL PHARMACEUTICALS LLC, AMNEAL PHARMACEUTICALS, INC., ARA APHRAMIAN, AUROBINDO PHARMA USA, INC., BAUSCH HEALTH AMERICAS, INC., DAVID BERTHOLD, BRECKENRIDGE PHARMACEUTICALS, INC., JAMES N. BROWN, JR, Bausch Health US LLC, Douglas Boothe, CITRON PHARMA, LLC, DR. REDDY'S LABORATORIES, INC., Tracy Sullivan Divalerio, EMCURE PHARMACEUTICALS, LTD., EPIC PHARMA, LLC, FOUGERA PHARMACEUTICALS, INC., Marc Falkin, G&W LABORATORIES, INC., GLENMARK PHARMACEUTICALS INC., USA, KEVIN GREEN, GREENSTONE LLC, James Grauso, ROBIN HATOSY, HERITAGE PHARMACEUTICALS, INC., HIKMA LABS, INC., HIKMA PHARMACEUTICALS USA, INC., IMPAX LABORATORIES, LLC, JUBILANT CADISTA PHARMACEUTICALS, INC., Armando Kellum, LANNETT COMPANY, INC., LUPIN PHARMACEUTICALS, INC., RAJIV MALIK, MAYNE PHARMA INC., SATISH MEHTA, MYLAN INC., MYLAN PHARMACEUTICAL CO., INC., Jill Nailor, James Nesta, Konstantin Ostaficiuk, NISHA PATEL, PERRIGO NEW YORK, INC., PFIZER INC, Michael Perfetto, David Rekenthaler, Richard Rogerson, SANDOZ, INC., SUN PHARMACEUTICAL INDUSTRIES, INC., Strides Pharma Inc., TARO PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS USA, INC., Torrent Pharma, Inc., UPSHER-SMITH LABORATORIES, LLC, VIATRIS INC., JOHN WESOLOWSKI, WEST-WARD PHARMACEUTICALS CORPORATION, West Ward Columbus Inc, ZYDUS PHARMACEUTICALS (USA) INC.. (Attachments: # 1 Exhibit A, # 2 Text of Proposed Order) (ADELSTEIN, ROBIN)